Kazia Therapeutics (KZIA) Interest & Investment Income (2019 - 2025)

Kazia Therapeutics has reported Interest & Investment Income for 7 years, with the latest figure at $105658.1 in Q4 2025.

• For the quarter ending Q4 2025, Interest & Investment Income rose 463.6% year-over-year to $105658.1; the trailing twelve-month figure through Dec 2025 stood at $105658.1 (up 463.6% YoY), and the FY2025 full-year result was $46111.2, up 483.07% from the prior year.
• Interest & Investment Income for Q4 2025 stood at $105658.1, up from $18747.0 in the prior quarter.
• The five-year high for Interest & Investment Income was $105658.1 in Q4 2025, with the low at $91.33 in Q4 2022.
• Historically, Interest & Investment Income has averaged $26029.2 across 5 years, with a median of $4200.8 in 2023.
• Annual changes were most pronounced in 2022 — Interest & Investment Income tumbled 93.7% — and 2023, when it soared 4499.83%.
• Kazia Therapeutics' Interest & Investment Income stood at $1449.0 in 2021, then plunged by 93.7% to $91.33 in 2022, then surged by 4499.83% to $4200.8 in 2023, then soared by 346.27% to $18747.0 in 2024, then jumped by 463.6% to $105658.1 in 2025.
• The last three Interest & Investment Income figures came in at $105658.1 (Q4 2025), $18747.0 (Q4 2024), and $4200.8 (Q4 2023), per Business Quant data.